Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity.

Santa Kumar DasKamal RanabhatSuraj BhattaraiKhem Bahadur KarkiPradip GyanwaliHem Raj PaneruBipin NepalShyam Prakash DumreSubhash Prasad Acharya

Published in: Clinical case reports (2021)

Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID-19 patients with obesity and chronic diseases such as diabetes and hypertension.

Keyphrases

coronavirus disease
sars cov
type diabetes
blood pressure
metabolic syndrome
cardiovascular disease
early onset
insulin resistance
drug induced
low dose
stem cells
glycemic control
weight gain
physical activity
body mass index
skeletal muscle
bone marrow
high fat diet induced
replacement therapy